LCI-HEM-MYE-CRD-002: Carfilzomib-Revlimid-Dexamethasone-Elotuzumab in Relapsed/Refractory Multiple Myeloma
Clinical trial NCT03361306 · COMPLETED
Trial details
- NCT number
- NCT03361306
- Sponsor
- Wake Forest University Health Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-09
- Primary completion
- 2021-06-04
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.